, a bio/informatics shared resource is still "open for business" - Visit the CDS website


  1. Signaling through non-membrane nuclear phosphoinositide binding proteins in human health and disease. Bryant JM, Blind RD (2019) J Lipid Res 60(2): 299-311
    › Primary publication · 30201631 (PubMed) · PMC6358298 (PubMed Central)
  2. Human islets expressing HNF1A variant have defective β cell transcriptional regulatory networks. Haliyur R, Tong X, Sanyoura M, Shrestha S, Lindner J, Saunders DC, Aramandla R, Poffenberger G, Redick SD, Bottino R, Prasad N, Levy SE, Blind RD, Harlan DM, Philipson LH, Stein RW, Brissova M, Powers AC (2019) J Clin Invest 129(1): 246-251
    › Primary publication · 30507613 (PubMed) · PMC6307934 (PubMed Central)
  3. Nuclear phosphoinositide regulation of chromatin. Hamann BL, Blind RD (2018) J Cell Physiol 233(1): 107-123
    › Primary publication · 28256711 (PubMed)
  4. Crystallographic and kinetic analyses of human IPMK reveal disordered domains modulate ATP binding and kinase activity. Seacrist CD, Blind RD (2018) Sci Rep 8(1): 16672
    › Primary publication · 30420721 (PubMed) · PMC6232094 (PubMed Central)
  5. Phospholipid regulation of the nuclear receptor superfamily. Crowder MK, Seacrist CD, Blind RD (2017) Adv Biol Regul : 6-14
    › Primary publication · 27838257 (PubMed) · PMC5292085 (PubMed Central)
  6. Inositol polyphosphate multikinase (IPMK) in transcriptional regulation and nuclear inositide metabolism. Malabanan MM, Blind RD (2016) Biochem Soc Trans 44(1): 279-85
    › Primary publication · 26862216 (PubMed) · PMC5380233 (PubMed Central)
  7. Structure of Liver Receptor Homolog-1 (NR5A2) with PIP3 hormone bound in the ligand binding pocket. Sablin EP, Blind RD, Uthayaruban R, Chiu HJ, Deacon AM, Das D, Ingraham HA, Fletterick RJ (2015) J Struct Biol 192(3): 342-348
    › Primary publication · 26416531 (PubMed) · PMC4651778 (PubMed Central)
  8. The signaling phospholipid PIP3 creates a new interaction surface on the nuclear receptor SF-1. Blind RD, Sablin EP, Kuchenbecker KM, Chiu HJ, Deacon AM, Das D, Fletterick RJ, Ingraham HA (2014) Proc Natl Acad Sci U S A 111(42): 15054-9
    › Primary publication · 25288771 (PubMed) · PMC4210282 (PubMed Central)
  9. Disentangling biological signaling networks by dynamic coupling of signaling lipids to modifying enzymes. Blind RD (2014) Adv Biol Regul : 25-38
    › Primary publication · 24176936 (PubMed) · PMC3946453 (PubMed Central)
  10. Ligand structural motifs can decouple glucocorticoid receptor transcriptional activation from target promoter occupancy. Blind RD, Pineda-Torra I, Xu Y, Xu HE, Garabedian MJ (2012) Biochem Biophys Res Commun 420(4): 839-44
    › Primary publication · 22465009 (PubMed) · PMC3340612 (PubMed Central)